E
Exero Medical
Exero Medical develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI surgery
About Exero Medical
Exero Medical specializes in the development of biodegradable wireless sensors designed for the early detection of anastomotic leaks following gastrointestinal (GI) surgeries, such as colorectal and bariatric procedures. These sensors continuously monitor the condition of the anastomosis area, providing real-time data to physicians and enabling preventive actions before complications arise. The primary clients for Exero Medical's technology are healthcare providers, including hospitals and surgical centers, that perform GI surgeries. The company operates in the medical technology market, focusing on innovative solutions to improve patient recovery and reduce healthcare costs. Exero Medical's business model revolves around the sale and distribution of its sensor systems to medical institutions. Revenue is generated through the direct sale of these sensors and potentially through service agreements for ongoing monitoring and data analysis. The company's technology aims to reduce diagnosis time lags, lower mortality rates, and alleviate the economic burden associated with postoperative complications.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 80.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotechnology, Medical & Healthcare, Biodegradable, Biosensors, Spinout
- Technology
- Hardware, Deep Tech, Autonomous & Sensor Tech, Connected Device
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Feb 2025 | $2.7M | — | Undisclosed | ↗ |
| SEED✓Equity / VC | Feb 2025 | $10M | $40M | Tech Council Ventures · Longevity Venture Partners · Edge Medical Ventures | ↗ |
Growth signals
Latest recorded traffic for Exero Medical is 520 monthly website visits, up 2500% over the last three months. Exero Medical's team grew 28.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Exero Medical in the Givatayim ecosystem
The Exero Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Consensus Business Group
MEDX Xelerator- TVTech Council Ventures
Longevity Venture Partners- EVEdge Medical Ventures
Other known investors1 additional known investor
Intellectual Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Exero Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Exero Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









